E-Book, Englisch, 272 Seiten
Handfield Biopharmaceutical Supply Chains
1. Auflage 2012
ISBN: 978-1-4665-6804-4
Verlag: Taylor & Francis
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Distribution, Regulatory, Systems and Structural Changes Ahead
E-Book, Englisch, 272 Seiten
ISBN: 978-1-4665-6804-4
Verlag: Taylor & Francis
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
A comprehensive exploration of the massive changes in the biopharmaceutical supply chain that have occurred during the past 10 years, and predicted future trends, Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead documents the specific impacts of these changes for key players in the supply chain.
Based on interviews with industry professionals, the book presents an overview of the key challenges and discusses how leading biopharmaceutical companies handle these challenges. It exposes the underlying structures that support the biopharmaceutical supply chain, focusing specifically on distribution—the point at which manufacturers release a finished product to the time that it is administered, and the complicated set of channels that exist between these two points. This overarching view of the supply chain provides an important piece of intelligence that can inform business strategy for life sciences manufacturers and distributors and help them achieve success in this industry.
Zielgruppe
Global executives in the biopharmaceutical industry, including manufacturers, wholesalers, software providers, hospital managers, government agencies tasked with managing pharmaceutical pricing and logistics; graduate-level students and faculty.
Autoren/Hrsg.
Fachgebiete
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Lagerhaltung und Versand
- Wirtschaftswissenschaften Betriebswirtschaft Bereichsspezifisches Management Einkauf, Logistik, Supply-Chain-Management
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
Weitere Infos & Material
Key Forces Driving the Biopharma Supply Chain
Key Forces
Compensation Forces
Channel Forces
Product Forces
Overview of Pharma Value Chain
Pharma Distribution
randed vs. Generic Manufacturers
Challenges in Pharma Distribution
Challenges in the Clinical Supply Chain
Intro
Plan Challenges
Source
Make
Deliver
Conclusions
Regulatory Trends
Intro
Regulatory Environment
Impact of Recent Legislation on Pharmaceutical and Biotech
The Race to the Bed Side, Specific to Hospitals
The Healthcare Imperative
Using New Technologies
The Journey Towards Automated Pharmaceutical Distribution
Future Applications of Cardinal ASSIST
Getting started with Cardinal ASSIST
Single unit bar code technology
Industry Reactions to Evolving Distribution Models
Intro, Background on Research Methods
Industry's Perception of Fee for Service Model
Alternative Channels on the Horizon
Impact on Reimbursement of Impending Legislation in Medicare and Medicaid
Next Steps
Compliance Issues
The Path Forward for the Industry
Emerging Forces and Trends
Opportunity: Customized Therapeutic Distribution
Opportunity: Compliance
Opportunity: Direct to Consumer Shipping for Oncology and Injected Biotherapeutics
Opportunity: New Warehouse Automation Technology
Opportunity: Data Integration
Opportunity: RFID Expansion
Opportunity: Cold Chain Technology and Pedigree Requirements
Conclusion